Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2007
03/13/2007US7189692 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same
03/13/2007US7189683 Non-ionic surfactants based upon alkyl polyglucoside
03/13/2007US7189537 Comprises oncogenic nucleotide sequences for use in diagnosis, prevention and treatment of various cancers; gene therapy and antisense agents
03/13/2007US7189518 Soluble CD40L(CD154) as a prognostic marker of atherosclerotic diseases
03/13/2007US7189421 Antiseptic composition
03/13/2007US7189420 Composition comprising wenguanguo extracts, methods for preparing same and uses thereof
03/13/2007US7189416 Method for stable and controlled delivery of (-)-hydroxycitric acid
03/13/2007US7189412 Co-micronized with solid surfactant; contains lactose and magnesium stearate; mixture with binder and disintegrator; bioavailability
03/13/2007US7189409 Porous carrier of ceramics or glass and pyrrolidone on the carrier for composites and bonding to carrier
03/13/2007US7189408 phosphate functionalized (per)fluoropolyethers, capable to confer improved protective hydro/oil-repellence properties to the formulation itself
03/13/2007US7189407 Composition for external use
03/13/2007US7189404 Strain selection of pneumococcal surface proteins
03/13/2007US7189383 Compounds with halogen for diagnosis with ethers or sulfides for cancer
03/13/2007US7189351 D-tagatose as an anti-biofilm agent
03/13/2007US7189234 Interspinous process implant sizer and distractor with a split head and size indicator and method
03/13/2007US7189196 Method of separating materials with a concentric tubular centrifuge
03/13/2007CA2420895C Method for treating erectile dysfunction and increasing libido in men
03/13/2007CA2398182C Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes
03/13/2007CA2387533C Purine derivatives
03/13/2007CA2381819C New benzimidazolone derivatives having mixed serotonine and dopamine receptors affinity
03/13/2007CA2376540C Process for preparing amlodipine benzenesulphonate
03/13/2007CA2365164C Method for selectively altering body fat level, feed efficiency, or weight gain
03/13/2007CA2315227C Arylpiperazines having activity at the serotonin 1a receptor
03/13/2007CA2295106C 3-anilino-2-cycloalkenone derivatives
03/13/2007CA2274756C Methods and pharmaceutical compositions for inhibiting tumour cell growth
03/13/2007CA2274592C Pyrazole derivatives
03/13/2007CA2274314C Insulin-like growth factor i (igf-i) expression system and methods of use
03/13/2007CA2273010C Use of green porphyrins for the manufacture of a medicament for the treatment of secondary cataracts
03/13/2007CA2271026C 3-amino-propoxyphenyl derivatives
03/13/2007CA2267224C Vitronectin receptor antagonists
03/13/2007CA2266581C Polymers containing polysaccharides such as alginates or modified alginates
03/13/2007CA2264063C Cryptophycin compounds
03/13/2007CA2263336C Neuraminic acid compounds
03/13/2007CA2259460C Recombinant canine adenovirus (cav) containing exogenous dna
03/13/2007CA2253230C Antioxidant compounds
03/13/2007CA2240494C Therapeutic molecules generated by trans-splicing
03/13/2007CA2228078C Composition for oral administration containing pyridazinone compounds
03/13/2007CA2219280C Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
03/13/2007CA2192899C Composition containing l-carnitine and hydroxycitric acid
03/13/2007CA2192209C Treatment of optic neuritis
03/13/2007CA2184395C Effective dosage form for antiepileptic drugs
03/13/2007CA2176461C Method for preparing low dose pharmaceutical products
03/13/2007CA2176460C Method for dry blend compression of medicaments
03/13/2007CA2176181C D4t polymorphic form i process
03/13/2007CA2171111C Inhibition of urinary calculi growth
03/13/2007CA2167578C Chicken anemia virus mutants and vaccines and uses based on the viral proteins vp1, vp2 and vp3 or sequences of that virus coding therefor
03/13/2007CA2116388C Treatment for viral diseases
03/13/2007CA2112866C Novel derivatives of 2-cyano-3-hydroxy-propenamides, a process for their preparation, their application as medicaments and pharmaceutical compositions containing them
03/12/2007CA2559510A1 Compositions and methods for reducing vaginal ph
03/12/2007CA2559407A1 Anhydrous composition containing an acid-acid buffer system
03/09/2007CA2559439A1 Compositions for inhibiting or reducing inflammation of skin
03/09/2007CA2559279A1 Compositions for inhibiting or reducing inflammation of skin
03/09/2007CA2558764A1 New association between agomelatine and a thymoregulator and the pharmaceutical compositions that contain it
03/09/2007CA2558762A1 Use of agomelatine to obtain medications for the treatment of sleep disorders in depressed patients
03/08/2007WO2007028171A1 Methods of using (+)-1,4-dihydro-7-[(3s,4s)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid for treatment of cancer
03/08/2007WO2007028163A1 Biocompatible fluorescent imaging agents
03/08/2007WO2007028154A2 Encapsulated arsenic drugs
03/08/2007WO2007028145A2 Agents and methods for reducing protein tyrosine phosphatase 1b activity in the central nervous system
03/08/2007WO2007028131A1 6-SUBSTITUTED 2,3,4,5-TETRAHYDRO-1H-BENZO[d]AZEPINES AS 5-HT2C RECEPTOR AGONISTS
03/08/2007WO2007028129A1 Hydroxy substituted 1h-imidazopyridines and methods
03/08/2007WO2007028104A2 Novel therapeutic agents for the treatment of cancer, metabolic diseases and skin disorders
03/08/2007WO2007028101A2 Osteogenic and anti-adiogenic oxysterols
03/08/2007WO2007028082A1 6-substituted- 2,3,4,5-tetrahydro-1h-benzo[d]azepines as 5-ht2c receptor agonists
03/08/2007WO2007028051A2 Novel imidazo based heterocycles
03/08/2007WO2007028050A1 Heterobifunctional pan-selectin inhibitors
03/08/2007WO2007028025A2 Methods and compositions for the treatment and prevention of cholera
03/08/2007WO2007028022A2 Novel compounds as p2x7 modulators and uses thereof
03/08/2007WO2007028020A2 Liposome compositions
03/08/2007WO2007027999A2 Chemical compounds
03/08/2007WO2007027987A2 Method of treating parkinson's disease with diarylmethylpiperazine compounds exhibiting delta receptor agonist activity
03/08/2007WO2007027959A1 Novel benzopyran derivatives as potassium channel openers
03/08/2007WO2007027878A2 4-substituted 2-aryloxyphenol derivatives as antibacterial agents
03/08/2007WO2007027849A2 Multiribbon nanocellulose as a matrix for wound healing
03/08/2007WO2007027842A1 Anilinopyrazole derivatives useful for the treatment of diabetes
03/08/2007WO2007027834A1 Carotenoid analogs or derivatives for the inhibition and amelioration of inflammation
03/08/2007WO2007027780A2 Benzopyran and pyranopyridine derivatives as potassium channel openers
03/08/2007WO2007027754A1 Bicyclic heterocycles as hiv integrase inhibitors
03/08/2007WO2007027734A2 Bicyclic and bridged nitrogen heterocycles
03/08/2007WO2007027733A2 Reverse link soft handoff in a wireless multiple-access communication system
03/08/2007WO2007027729A1 3, 5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
03/08/2007WO2007027718A1 Methods of altering an immune response induced by cpg oligodeoxynucleotides
03/08/2007WO2007027675A1 Therapy for the treatment of disease
03/08/2007WO2007027636A2 Method for treatment or prevention of conditions caused by gram-positive bacteria
03/08/2007WO2007027599A1 9-aminocarbonylsubstituted derivatives of glycylcyclines
03/08/2007WO2007027594A1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
03/08/2007WO2007027582A2 Treating renal disease, burns, wounds and spinal cord injury with selective androgen receptor modulators
03/08/2007WO2007027560A2 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents
03/08/2007WO2007027532A2 Niacin receptor agonists, compositions containing such compounds and methods of treatment
03/08/2007WO2007027528A2 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-.receptor tyrosine kinases
03/08/2007WO2007027525A1 Novel crystalline form of a pyridazino [4 , 5-b] indole derivative
03/08/2007WO2007027524A2 Halo active aromatic sulfonamide organic compounds and odor control uses therefor
03/08/2007WO2007027494A2 Morphous solid dispersions of 7-chloro-n,n, 5-trimethyl-4-oxo-3-phenyl-3, 5,-dihydro-4h-pyridazino [4, 5-b] indole-1-acetamide
03/08/2007WO2007027477A2 Treating vulvodynia using prodrugs of gaba analogs
03/08/2007WO2007027468A1 Ep2 receptor agonists for treating glaucoma
03/08/2007WO2007027454A1 Heterocyclic dihydropyrimidine compounds
03/08/2007WO2007027314A2 Anti-inflammatory compositions and methods of use
03/08/2007WO2007027248A2 3', 5' - cyclic nucleoside analogues for treatment of hcv
03/08/2007WO2007027238A2 Jak kinase inhibitors and their uses
03/08/2007WO2007027236A2 Composition and method for treating nosebleeds
03/08/2007WO2007027233A2 Derivatives of 6,7-dihydro-5h-imidazo[1,2-a]imidazole-3-sulfonic acid
1 ... 3844 3845 3846 3847 3848 3849 3850 3851 3852 3853 3854 3855 3856 3857 3858 3859 3860 3861 3862 3863 3864 ... 7860